Patents for C07D 295 - Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms (34,005) |
---|
10/21/2004 | WO2004065380A8 1,2,3-trisubstituted aryl and heteroaryl derivatives as modulators of metabolism and the prpphylaxis and treatment of disorders related thereto such as diabetes and hyperglycemia |
10/21/2004 | US20040210080 3-(oxo, oxime, hydrazone, or alkylidene)-fluorene derivatives; can be synergistically combined with other anticarcinogenic, anticholesterol, anxiolytic agents, antidepressants or enzyme inhibitors; bone disorders |
10/21/2004 | US20040210051 Inhibitors of binding between vascular cell adhesion molecules and cells expressing vla-4 integrin; antiinflammatory agents |
10/21/2004 | US20040209949 Resorcinol derivatives |
10/21/2004 | US20040209873 Arylcycloalkyl derivatives having branched side chains, processes for their preparation and their use as pharmaceuticals |
10/21/2004 | US20040209872 Calcium channel blockers comprising two benzhydril moieties |
10/21/2004 | US20040205909 Novel couplers for use in oxidative hair dyeing |
10/21/2004 | US20040205907 Making 2-amino-5-substituted-amino-phenol derivatives by reduction, hydrogenation, amination, hydroxylation; oxidation color dyes, hair dye mixture including coupler and developer oxidizers, yellow color shades, colorfastness |
10/21/2004 | CA2521875A1 Calcium channel blockers comprising two benzhydril moieties |
10/21/2004 | CA2521330A1 Calcium channel inhibitors comprising benzhydril spaced from piperazine |
10/21/2004 | CA2521228A1 Biphenyl carboxylic amide p38 kinase inhibitors |
10/21/2004 | CA2521000A1 Preventive and/or therapeutic agent for neuropathic pain |
10/20/2004 | EP1468999A1 Substituted piperidine and piperazine derivatives as melanocortin-4 receptor modulators |
10/20/2004 | EP1468994A1 Process for preparing cyclic amine substituted phenyl-alkyl-ketones |
10/20/2004 | EP1468990A1 Piperazine derivative |
10/20/2004 | EP1467989A1 Proline compounds as ns3-serine protease inhibitors for use in treatment of hepatitis c virus infection |
10/20/2004 | EP1467977A1 Novel antibacterial compounds:process for their preparation and pharmaceutical compositions containing them. |
10/20/2004 | EP1467723A1 Phenyl sulfoxides and phenyl sulfones |
10/20/2004 | EP1467695A2 Hiv integrase inhibitors |
10/20/2004 | EP1311472B1 Method for preparing alkoxyamines from nitroxides |
10/20/2004 | EP1282611B1 Substituted phenylacetamides and their use as glucokinase activators |
10/20/2004 | EP1263725B1 Novel compounds |
10/20/2004 | EP1233954B1 A process for the preparation of 2- 4-(alpha-phenyl-p-chlorobenzyl)piperazin-1-yl]ethoxy acetic acid and novel intermediates therefor |
10/20/2004 | EP1149074B1 Acetylenic sulfonamide thiol tace inhibitors |
10/20/2004 | EP1056720B1 Phtalimido arylpiperazines as alpha 1a receptor antagonists useful in the treatment of benign prostatic hyperplasia |
10/20/2004 | CN1538951A Omega-aminoalkylamides of R-2-aryl-propionic acids as inhibitors of chemotaxis of polymorphonucleate and mononucleate cells |
10/20/2004 | CN1537847A Internediate for preparing quetiapin and preparation method of the intermediate |
10/20/2004 | CN1171869C Carbamic acid ester compound with N-substituted thiocarbamoyl group and its producing process |
10/20/2004 | CN1171863C Carbamate derivatives and agricultural/horticulatrual bactericides |
10/19/2004 | US6806365 N-alkanoylphenylalamine derivatives |
10/14/2004 | WO2004087700A1 Benzenesulphonamide derivatives, method for production and use thereof for treatment of pain |
10/14/2004 | WO2004087685A2 Phospholipase c inhibitors for use in treating inflammatory disorders |
10/14/2004 | WO2004087654A2 Phospholipase c inhibitors for use in treating inflammatory disorders |
10/14/2004 | WO2004087644A1 Mercapto-phenyl-naphthyl-methane derivatives and preparation thereof |
10/14/2004 | WO2004087643A1 Deformylase inhibitor, process for preparing the same, and antibacterial composition comprising the same |
10/14/2004 | US20040204591 Reacting an amide compound containing hydroxy and a carboxyl group and having benzene ring, with a halogenated alkyl aminocarbonyl-pyrrolidine with 2-fluoro groups substituted at the ring carbon, by amindation of amine and carboxyl group |
10/14/2004 | US20040204583 Aminophenoxyethyl quaternary ammonium halides or sulfates, e.g., (2-(3-dimethylaminophenoxy)ethyl)trimethylammonium bromide |
10/14/2004 | US20040204582 Substituted sulfonamides and ureas useful for inhibiting kinase activity |
10/14/2004 | US20040204460 Sodium channel modulators |
10/14/2004 | US20040204370 such as N-deacetyl-N-(4-fluorophenoxyacetyl)thiocolchicine; liposomes; antitumor agents; anticancer agents |
10/13/2004 | EP1466899A1 Hydroxamic acid derivative and mmp inhibitor containing the same as active ingredient |
10/13/2004 | EP1466898A1 Beta-amyloid protein production/secretion inhibitors |
10/13/2004 | EP1466891A1 Carboxylic acid derivative |
10/13/2004 | EP1466889A1 Derivatives of venlafaxine and methods of preparing and using the same |
10/13/2004 | EP1466605A2 Calcium channel blockers |
10/13/2004 | EP1466585A2 Use of of aminosubstituted hydroxybenzophenones as photostable UV-filter in cosmetic and pharmaceutical preparations |
10/13/2004 | EP1465892A1 Glycinamides as factor xa inhibitors |
10/13/2004 | EP1465891A2 Inhibitors of dipeptidyl peptidase iv |
10/13/2004 | EP1465867A1 Ligands of melanocortin receptors and compositions and methods related thereto |
10/13/2004 | EP1465863A1 Potassium channel modulators |
10/13/2004 | EP1465862A1 Cycloalkyl ketoamides derivatives useful as cathepsin k inhibitors |
10/13/2004 | EP1465861A1 Alpha-(n-sulphonamido)acetamide derivatives as beta-amyloid inhibitors |
10/13/2004 | EP1465611A2 Composition, synthesis and therapeutic applications of polyamines |
10/13/2004 | EP1465607A1 Pharmaceutical formulations with modified release |
10/13/2004 | EP1465488A1 Arylamines as inhibitors of chemokine binding to us28 |
10/13/2004 | EP1165533B1 Compounds and methods for treatment of asthma, allergy and inflammatory disorders |
10/13/2004 | EP1107745B1 Use of 5ht-6 antagonists for the treatment of adhd |
10/13/2004 | EP0999204B1 Novel compound having effect of promoting neuron differentiation |
10/13/2004 | CN1537016A Remedies for psychoneurosis |
10/13/2004 | CN1535961A Non-sterioid inflammation-resisting compound |
10/13/2004 | CN1170813C N2 phenylamidine derivatives and fungicidal composition and use |
10/13/2004 | CN1170810C Hydrogenation of imine and enamine |
10/12/2004 | US6803465 Optically active 4-(tert-butoxycarbonyl)piperazine compound, and method for producing the same |
10/12/2004 | US6803384 Diaminopropionic acid derivatives |
10/12/2004 | US6803381 Carbamic acid derivatives |
10/07/2004 | WO2004086050A2 Labelling agents for mass spectrometry comprising tertiary amines |
10/07/2004 | WO2004085661A2 Process to chiral beta-amino acid derivatives |
10/07/2004 | WO2004085385A2 Cannabinoid receptor ligands |
10/07/2004 | WO2004084898A1 2-phenoxy- and 2-phenylsulfomamide derivatives with ccr3 antagonistic activity for the treatment of asthma and other inflammatory or immunological disorders |
10/07/2004 | WO2004047738A3 Arylcyclopropylcarboxylic amides as potassium channel openers |
10/07/2004 | US20040199033 Method for hydrogenating organic compounds by means of ru/sio2 catalysts |
10/07/2004 | US20040199002 Process for producing(2-nitrophenyl)acetonitrile derivative and intermediate therefor |
10/07/2004 | US20040198982 such as (4S)-1-(3-bromophenyl)-N-cyanomethyl)-4-methyl-prolinamide; for treatment of osteoporosis |
10/07/2004 | US20040198720 3-(Arylamino)methylene-1, 3-dihydro-2H-indol-2-ones as kinase inhibitors |
10/07/2004 | CA2519401A1 Cannabinoid receptor ligands |
10/06/2004 | EP1464641A1 4-Phenyl-piperazinyl, -piperidinyl and tetrahydropyridyl derivatives as dopamine D4 antagonists |
10/06/2004 | EP1463717A2 Process for the synthesis of amine ethers from secondary amino oxides and uses |
10/06/2004 | EP1463715A1 Novel glucagon antagonists |
10/06/2004 | EP1135379B1 Antitumor dibenzofluorene derivatives |
10/06/2004 | EP1101755B1 Anthranilic acid derivatives |
10/06/2004 | EP1098864B1 Method for hydrogenating unsaturated heterocyclic compounds |
10/06/2004 | CN1535260A Perfluoroalkyl-substituted amines, acids, amino acids and thioether acids |
10/06/2004 | CN1534029A Method of synthesizing N-amylidene-N'-cumin urea kind compound |
10/06/2004 | CN1534017A N-(2-phenyl-4-amino-batyl)-1-naphthol carboxy amide kind compound used as neuropeptide-1-acceptor antagonistic agent |
10/05/2004 | US6800097 For dyeing keratin fibers; hair dyes |
10/05/2004 | CA2103837C Novel method of producing 7-(substituted)-9-[(substituted glycyl)amido]-6-demethyl-6-deoxytetracyclines |
10/05/2004 | CA2103836C 7-(substituted)-9-[(substituted glycyl)-amido]-6-demethyl-6-deoxytetracyclines |
09/30/2004 | WO2004083208A1 Substituted piperidine and piperazine derivatives as melanocortin-4 receptor modulators |
09/30/2004 | WO2004083167A1 Sulfamide derivative and medicinal composition thereof |
09/30/2004 | WO2004082682A1 Amino cyclobutylamide modulators of chemokine receptor activity |
09/30/2004 | WO2004082677A1 Substituted p-diaminobenzene derivatives |
09/30/2004 | WO2004058705B1 Inhibitors of the binding of chemokines i-tac or sdf-1 to the ccxckr2 receptor |
09/30/2004 | WO2004050022B1 Phenylalanine derivatives as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes |
09/30/2004 | WO2003072535A8 Substituted hydroxyethylamines |
09/30/2004 | US20040192921 Oximationof isobutyl (2-piperidineophenyl )ketone with hydroxyamine hydrochloride; solvent extraction; chemical intermediate for hypoglycemic agent repaglinide |
09/30/2004 | US20040192742 Antiarthritic agents; muscular dystrophy; antiinflammatory agents; glomerulonephritis; malaria; oral diseases |
09/30/2004 | US20040192703 Preferentially substituted calcium channel blockers |
09/30/2004 | US20040192702 Heteroaryl alkyl piperazine derivatives |
09/30/2004 | US20040192691 Analgesics; antiischemic agents; amyotrophic lateral sclerosis; anticonvulsants; antidepressants; local anesthetics; antiarrhythmia agents; neuropathic pain |
09/30/2004 | US20040192688 Hyperglycemic agents; cardiovascular disorders; antilipemic agents; anticholesterol agents |